| 摘要 |
<p>The present invention relates to pharmaceutical compositions containing peptides capable of binding to the α2-macroglobulin receptor/low density lipoprotein receptor-related protein (α2-MR/LRP) and a method for the prevention or treatment of indications involving interaction between the α2-MR/LRP and a lipoprotein or a lipoprotein lipase or a complex of a lipoprotein and a lipoprotein lipase.</p> |
